New drug trial aims to protect kidneys in lupus patients
NCT ID NCT07393451
Summary
This study is testing whether an experimental drug called SIM0278 can help control kidney damage in people with active lupus nephritis. About 60 adults will receive either SIM0278 or a placebo for one year, along with standard lupus medications, to see which group has better kidney outcomes. The main goal is to see if more people taking SIM0278 achieve a meaningful improvement in kidney function compared to those taking the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Medical College Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.